| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Laboratoire de Neurobiologie Cellulaire et Moléculaire, CNRS, Gif sur Yvette, France.
1. The effects of botulinum toxin (BoTx) types A and D on spontaneous and evoked phasic transmitter release were studied in the isolated extensor digitorum longus muscle of the rat or the levator auris longus muscle of mice. 2. The toxins were injected subcutaneously into the hindleg of adult rats or the dorsal aspect of the neck of mice. At various times after the injection the muscles were removed from the anaesthetized animal and neuromuscular transmission examined in vitro by conventional intracellular techniques. 3. Both toxins reduced spontaneous transmitter release recorded as the frequency of miniature end-plate potentials but BoTx type D was less effective in that respect than the type A toxin. 4. With both toxins the block of evoked phasic transmitter release, recorded as end-plate potentials, was almost complete. As previously reviewed by Simpson (1986) the block produced by BoTx type A was partially reversed by procedures which elevate the intraterminal level of calcium ions. However, in BoTx type D-paralysed muscles such procedures failed to restore phasic transmitter release but caused a period of high-frequency asynchronous transmitter release following each nerve impulse. 5. To investigate if the lack of synchronization of evoked transmitter release observed in BoTx type D-paralysed muscles was due to alterations in presynaptic currents we examined, by perineural recordings, the Na+, fast K+, slow K+, K+-Ca2+-dependent and the Ca2+ currents in BoTx type D-paralysed muscles. These presynaptic currents were not altered as compared to unpoisoned controls. 6. We suggest that there exists a presynaptic process, which in addition to Ca2+ influx participates in transmitter synchronization and which is a main target for BoTx type D action.
This article has been cited by other articles:
|
|
 |
|
  E. M. Silinsky Selective disruption of the mammalian secretory apparatus enhances or eliminates calcium current modulation in nerve endings PNAS, April 29, 2008; 105(17): 6427 - 6432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sakaba Roles of the fast-releasing and the slowly releasing vesicles in synaptic transmission at the calyx of held. J. Neurosci., May 31, 2006; 26(22): 5863 - 5871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M Silinsky Modulation of calcium currents is eliminated after cleavage of a strategic component of the mammalian secretory apparatus J. Physiol., August 1, 2005; 566(3): 681 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Pastor, G. Z. Mentis, R. R. De la Cruz, E. Diaz, and R. Navarrete Increased Electrotonic Coupling in Spinal Motoneurons After Transient Botulinum Neurotoxin Paralysis in the Neonatal Rat J Neurophysiol, February 1, 2003; 89(2): 793 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schiavo, M. Matteoli, and C. Montecucco Neurotoxins Affecting Neuroexocytosis Physiol Rev, April 1, 2000; 80(2): 717 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-E. Trudeau, Y. Fang, and P. G. Haydon Modulation of an early step in the secretory machinery in hippocampal nerve terminals PNAS, June 9, 1998; 95(12): 7163 - 7168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Keller and E. A. Neale The Role of the Synaptic Protein SNAP-25 in the Potency of Botulinum Neurotoxin Type A J. Biol. Chem., April 13, 2001; 276(16): 13476 - 13482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Stewart, M. Mohtashami, W. S. Trimble, and G. L. Boulianne SNARE proteins contribute to calcium cooperativity of synaptic transmission PNAS, December 5, 2000; 97(25): 13955 - 13960. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
